Navigation Links
PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
Date:4/10/2008

king statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the period ended December 31, 2007 as filed with the SEC on February 7, 2008, which "Risk Factors" discussion is incorporated by reference in this press release. The forward-looking statements included in this press release represent the Company's estimates as of the date of this release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and PERCEPTIVE INFORMATI
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
2. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
3. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
4. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
5. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
6. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
7. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
8. PAREXEL International Announces 2-For-1 Stock Split
9. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
10. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
11. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015 HUYA Bioscience International (HUYA) today announced the ... Society of HTLV-1, held this week at the University ... the Society is to promote research on HTLV-1 and ... technology and research related to these fields to advance ... is proud to support this prestigious conference," said ...
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual list of the ... 1,361 in growth for the three years through 2014. Being named to the Inc. ... organizations in the country. , “We are thrilled to make the Inc. 5000 ...
(Date:8/27/2015)... N.C. , Aug. 27, 2015 ... decision by FedEx, UPS and The US Postal ... biological specimens classified as ,select agents, by the ... history of handling these sensitive shipments. ... global transportation regulations, trained and certified personnel to ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, ... second US laboratory is to open in Manhattan, Kansas in early October, 2015. ... long-term growth of research and development through collaboration with researchers from Kansas State ...
Breaking Biology Technology:HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Marken Ensures Safe Transportation Of Select Agents And Toxins 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3
... , , SOUTHAMPTON, Pa., Aug. 4 ... or the "Company") BioMedical Systems Division has been contracted ... installation of one BARA-MED((R)) monoplace hyperbaric chamber. The chamber ... Ltd. , , Hospimedica International Pvt. ...
... BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE AMEX: ... China, announced today,that the clinical trial of its A/H1N1 influenza ... shot of the vaccine and, during the,three day observation period, ... and reliable in humans. , The ...
... Md., Aug. 3 Human Genome Sciences, Inc. (Nasdaq: ... offering of 26,697,250 newly issued shares of its common stock ... which includes 3,482,250 shares sold upon exercise by the underwriters ... proceeds to the Company from the offering are approximately $356.7 ...
Cached Biology Technology:ETC Biomedical Announces Chamber Sale in India 2ETC Biomedical Announces Chamber Sale in India 3ETC Biomedical Announces Chamber Sale in India 4Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials 2Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials 3Human Genome Sciences Announces Closing of Public Offering 2Human Genome Sciences Announces Closing of Public Offering 3
(Date:8/5/2015)... Transparency Market Research has released ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... is forecast to reach US$ 2,671.8 Mn by 2022. ... systems by civil and government agencies. This is majorly ... activities across the globe that would elevate the demand ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... Scientists from the National Institute of Allergy and ... of Health, have determined how a promising drug ... Published online this week in Proceedings of the ... scientists optimize the drug candidate, PA-824, which targets ...
... a new front in the war on cancer, bringing ... and introducing a unique nanobomb that can literally blow ... professor of electrical and computer engineering at UD, has ... and Oncology Issues. , Panchapakesan said this is ...
... live beyond their fertile years, biologists have searched for ... any, does natural selection play in the evolution of ... to shape the twilight years, postreproductive females should contribute ... hypothesis called the "grandmother effect." Though many mammals, including ...
Cached Biology News:NIAID researchers show how promising TB drug works 2NIAID researchers show how promising TB drug works 3University of Delaware researchers develop cancer 'nanobomb' 2University of Delaware researchers develop cancer 'nanobomb' 3University of Delaware researchers develop cancer 'nanobomb' 4Getting an evolutionary handle on life after reproduction 2
Mouse polyclonal antibody to BTG2 - BTG family, member 2...
... to quantitate double-stranded DNA (dsDNA) in solution, even ... this kit, DNA is stained with Hoechst 33258 ... or other fluorometer. The kit quantitates dsDNA in ... 5 micrograms per ml and contains Hoechst 33258, ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
... of microplate readers combines reagent dispensing with ... affordable, easy-to-use platform for the complete range ... design and adaptability of the Infinite 200 ... a monochromator (M200) or filter (F200) system ...
Biology Products: